Skip to content
Screener

Total Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$27.42B+14.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
$566.74M+36.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$443.28M+8.9%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$530.65M+29.5%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$535.54M-9.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$1.29B+81.1%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$48.0M-31.7%
Net income-$44.7M-32.8%
EPS (diluted)-$0.76+1.3%

Balance sheet

See full
Cash & equivalents$202.6M-23.4%
Total debt$60.4M+142%
Total equity$453.1M+72.8%

Cash flow

See full
Operating cash flow-$15.1M+49.9%
CapEx$107.0K-72.8%
Free cash flow-$15.2M+50.2%

Valuation

See full
Market cap$1.51B+156%
Enterprise value$1.37B+290%

Returns & leverage

See full
Return on equity-37.3%
Debt / equity0.1×0.0×
Current ratio18.3×+4.7×

Where this comes from

Reported directly by Maze Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:48 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344903

FAQ

What is Maze Therapeutics's total assets?
Maze Therapeutics (MAZE) reported total assets of $531.63M in Q2 2026.
How has Maze Therapeutics's total assets changed year-over-year?
Maze Therapeutics's total assets increased by 75.2% year-over-year, from $303.52M to $531.63M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Maze Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude